Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Coherus Bio (NQ: CHRS )

17.56 USD +1.53 (+9.54%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 17, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,610,818
Open 16.25
Bid (Size) 17.45 (23)
Ask (Size) 17.60 (3)
Prev. Close 16.03
Today's Range 16.16 - 17.79
52wk Range 12.21 - 22.22
Shares Outstanding 76,480,152
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Junshi Biosciences and Coherus to Present Positive Progression Free Survival and Overall Survival Results from JUPITER-06, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemother
From GlobeNewswire News Releases
Coherus and Junshi Biosciences to Present Positive Progression Free Survival and Overall Survival Results from JUPITER-06, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemother
From GlobeNewswire News Releases

Performance

YTD
+3.84%
+3.84%
1 Month
+20.85%
+20.85%
3 Month
+18.97%
+18.97%
6 Month
+11.00%
+11.00%
1 Year
-11.71%
-11.71%

More News

Read More
Junshi Biosciences and Coherus Announce Results from Phase 3 Study of Toripalimab Published in September Issue of Nature Medicine
From GlobeNewswire News Releases
Coherus and Junshi Biosciences Announce Results from Phase 3 Study of Toripalimab Published in September Issue of Nature Medicine
From GlobeNewswire News Releases
Positive Interim Results of CHOICE-01 Study Evaluating Junshi Biosciences and Coherus’ Toripalimab for First Line Treatment of Non-Small Cell Lung Cancer Presented at World Conference on Lung Cancer
From GlobeNewswire News Releases
Positive Interim Results of CHOICE-01 Study Evaluating Coherus' and Junshi Biosciences’ Toripalimab for First Line Treatment of Non-Small Cell Lung Cancer Presented at World Conference on Lung Cancer
From GlobeNewswire News Releases
Coherus Management to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
From GlobeNewswire News Releases
Coherus BioSciences Announces Upcoming Medical Conference Presentations
From GlobeNewswire News Releases
Coherus and Junshi Biosciences Announce Completion of Rolling BLA Submission to U.S. FDA for Toripalimab for the Treatment of Nasopharyngeal Carcinoma
From GlobeNewswire News Releases
Junshi Biosciences and Coherus Announce Completion of Rolling BLA Submission to U.S. FDA for Toripalimab for the Treatment of Nasopharyngeal Carcinoma
From GlobeNewswire News Releases
Coherus BioSciences Announces New Employment Inducement Grants
From GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.